BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, January 30, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 5, 2020

View Archived Issues

EZH2 has dual role

Read More

Imitating ticks to evade immunity

Read More

ValiRx collaborates with Oncolytika and Black Cat Bio to explore combination treatment for COVID-19

Read More

Inovio and partners to initiate phase I/II study of COVID-19 DNA vaccine in South Korea

Read More

Intravacc announces partnership to develop intranasal COVID-19 vaccine

Read More

IRLAB announces preparations for phase IIb/III study of mesdopetam in PD

Read More

PharmAust reports preliminary data for monepantel in models of SARS-CoV-2 infection

Read More

CytomX presents first-in-human data for CX-2029

Read More

Onconova Therapeutics describes multi-specific protein kinase inhibitors

Read More

Type-1 angiotensin II receptor antagonists discovered at MFC

Read More

Forge Therapeutics patents bacterial LpxC inhibitors

Read More

New JAK1 inhibitors identified at HK inno.N Corp.

Read More

Phase I data for mRNA-2752 as monotherapy or in combination with durvalumab

Read More

Nippon Shinyaku discovers pim-1 kinase inhibitors

Read More

Selective TREK channel activator alleviates pain in mice without opioid-like adverse effects

Read More

Identification of inhibitors of the main protease of SARS-CoV-2

Read More

Results presented for GC-1118 with irinotecan or FOLFIRI in patients with metastatic solid tumors

Read More

Meiji Seika Pharma discontinues development of ME-1111 for treatment of onychomycosis

Read More

Phase III STEP 1 trial of semaglutide in obesity meets primary endpoints

Read More

Molecular pair offers potential Parkinson's treatment

Read More

FDA places clinical hold on phase II/III trial of LYS-SAF-302 gene therapy for MPS IIIA

Read More

FDA approves Recarbrio for hospital-acquired and ventilator-associated bacterial pneumonia

Read More

FDA clears IND for phase I/II trial of autologous cell therapy EXG-34217

Read More

Anti-PD-1 MAb zimberelimab shows promise in patients with recurrent or metastatic cervical cancer

Read More

PDS Biotechnology announces phase II trial of PDS-0101 with chemoradiotherapy for cervical cancer

Read More

DMX-200 to be studied for COVID-19 within REMAP-CAP program

Read More

CEPI supports development of BBV-87 vaccine against Chikungunya

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 29, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 29, 2026.
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Brain with stroke illustration

    Brain-derived tau in blood predicts stroke severity and outcome

    BioWorld Science

    Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

  • Centessa’s CNT-9982 shows promise for MDD

    BioWorld Science
    Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing